Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-08 Sale |
2024-11-12 4:13 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,787 | $36.3 | $391,568 | 13,315 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 4:11 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
14,213 | $36.62 | $520,480 | 24,102 (Direct) |
View |
| 2024-09-13 Sale |
2024-09-17 4:10 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
13,886 | $31.33 | $435,048 | 38,315 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-01 5:12 pm |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
14,090 | $0 | $0 | 0 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-07 4:48 pm |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
10,000 | $33 | $330,000 | 24,090 (Direct) |
View |
| 2020-07-29 Sale |
2020-07-30 7:03 pm |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
10,000 | $30 | $300,000 | 34,090 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Option Award |
2025-02-24 5:45 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
5,369 | $0 | 18,684 (Direct) |
View |
| 2025-02-19 Option Award |
2025-02-21 4:49 pm |
N/A 2035-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
11,771 | $0 | 25,086 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 4:13 pm |
2016-03-23 2025-03-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,787 | $0 | 13,315 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 4:13 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,787 | $11.46 | 13,315 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:11 pm |
2016-03-23 2025-03-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
14,213 | $0 | 24,102 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:11 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
14,213 | $11.46 | 24,102 (Direct) |
View |
| 2024-09-13 Exercise |
2024-09-17 4:10 pm |
2016-03-23 2025-03-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,000 | $0 | 38,315 (Direct) |
View |
| 2024-09-13 Exercise |
2024-09-17 4:10 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,000 | $11.46 | 38,315 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:15 pm |
N/A 2034-06-11 |
Disc Medicine Inc. | IRON | GEMAYEL GEORGES Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
3,886 | $0 | 17,201 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:03 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
13,621 | $0 | 26,936 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-09 6:24 pm |
N/A 2033-06-08 |
Disc Medicine Inc. | IRON | GEMAYEL GEORGES Director |
7,136 | $0 | 7,136 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,179 | $0 | 23,494 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:14 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
3,882 | $0 | 13,315 (Direct) |
View |
| 2022-12-29 Option Award |
2023-01-03 5:17 pm |
N/A 2032-12-28 |
Disc Medicine Inc. | IRON | GEMAYEL GEORGES Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:22 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,729 | $0 | 20,162 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:17 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
4,222 | $0 | 9,433 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:04 pm |
N/A 2032-01-02 |
Gemini Therapeutics Inc. | GMTX | GEMAYEL GEORGES Executive Chair of the Board |
793,274 | $0 | 793,274 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-16 07:56 am |
N/A 2031-11-14 |
Gemini Therapeutics Inc. | GMTX | GEMAYEL GEORGES See Remarks |
40,759 | $0 | 40,759 (Direct) |
View |
| 2021-04-29 Option Award |
2021-05-03 4:02 pm |
N/A 2031-04-28 |
Gemini Therapeutics Inc. | GMTX | GEMAYEL GEORGES Director |
45,466 | $0 | 45,466 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:48 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
11,587 | $0 | 16,798 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 4:48 pm |
2018-01-01 2026-01-01 |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
10,000 | $0 | 24,090 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 4:48 pm |
N/A N/A |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
10,000 | $14.84 | 24,090 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-30 7:03 pm |
2017-01-01 2026-01-01 |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
10,000 | $0 | 34,090 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-30 7:03 pm |
N/A N/A |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
10,000 | $14.84 | 34,090 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-24 5:46 pm |
N/A 2030-06-23 |
MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director |
25,000 | $0 | 25,000 (Direct) |
View |